Cetaphil Restoraderm Effect on Young Children With Atopic Dermatitis

Launched by GALDERMA R&D · Oct 27, 2015

Keywords

ClinConnect Summary

Two groups randomized in a ratio of \[1:1\] for a 12-week period Five study evaluation were planned: at Baseline, week 2, Week 4, Week8 and Week12

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Male or female subject, aged 2 to 12 years inclusive
• • Controlled mild to moderate atopic dermatitis with a Investigator Global Assessment score at 0 or 1, within one week after successful treatment with topical corticosteroid.
• Exclusion Criteria:
• • Subject presenting bacterial, viral, fungal or parasite skin infection
• • Subject with ulcerated lesions, acne or rosacea
• • Immunosuppression
• • Subject with a wash-out period from baseline for topical treatment less than 8 days for Calcineurin inhibitor
• • Subject with a wash-out period from baseline for topical treatment more than 8 days for corticosteroid
• • Subject with a wash-out period from baseline for systemic treatment less than 8 days for anti-histamines, less than 4 weeks for immunomodulators